IP Library Granted Patent US 7,622,292
Granted Patent B2
US 7,622,292 · App. 11/936,155 · Granted Nov 24, 2009

Regulation of human transmembrane serine protease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,622,292
App. No.
11/936,155
Granted
Nov 24, 2009
Kind
B2
Abstract

Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.

Claims (10)

1. A purified polypeptide comprising an amino acid sequence selected from the group consisting of (a) the amino acid sequence shown in SEQ ID NO: 12, and (b) the amino acid sequence of the human transmembrane serine protease encoded by a cDNA insert contained within plasmid pCRII-TMSP3 (ATCC Accession No. PTA-3433).

2. The purified polypeptide of claim 1 which comprises the amino acid sequence shown in SEQ ID NO:12.

3. The purified polypeptide of claim 2 which consists of the amino acid sequence shown in SEQ ID NO:12.

4. The purified polypeptide of claim 1 which comprises the amino acid sequence of the human transmembrane seine protease encoded by the cDNA insert of plasmid pCRII-TMSP3.

5. The purified polypeptide of claim 1 which consists of the amino acid sequence of the human transmembrane seine protease encoded by the cDNA insert of plasmid pCRII-TMSP3.

6. A fusion protein comprising a polypeptide consisting of an amino acid sequence selected from the group consisting of (a) the amino acid sequence shown in SEQ ID NO: 12, and (b) the amino acid sequence of the human transmembrane seine protease encoded by a cDNA insert contained within plasmid pCRII-TMSP3 (ATCC Accession No. PTA-3433).

7. The fusion protein of claim 6 wherein the polypeptide comprises the amino acid sequence shown in SEQ ID NO:12.

8. The fusion protein of claim 6 wherein the polypeptide consists of the amino acid sequence shown in SEQ ID NO:12.

9. The fusion protein of claim 6 wherein the polypeptide comprises the amino acid sequence of the human transmembrane seine protease encoded by the cDNA insert of plasmid pCRII-TMSP3.

10. The fusion protein of claim 6 wherein the polypeptide consists of the amino acid sequence of the human transmembrane serine protease encoded by the cDNA insert of plasmid pCRII-TMSP3.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →